期刊文献+

MALT淋巴瘤病因及发病机制研究进展 被引量:21

Research Progress on the Etiology and Pathogenesis of MALT Lymphoma——Review
下载PDF
导出
摘要 黏膜相关淋巴组织(MALT)淋巴瘤为起源于淋巴结外MALT的低度恶性B细胞淋巴瘤,是非霍奇金淋巴瘤中边缘区B细胞淋巴瘤最常见类型。MALT淋巴瘤常发生于胃、唾液腺、甲状腺及眼眶附属器等部位,其中发生于胃肠道的病例占全部MALT淋巴瘤的50%,胃肠道MALT淋巴瘤已证实与幽门螺杆菌(HP)感染有关,其主要机制为免疫反应,在部分染色体易位患者抗HP治疗无效,提示存在其他致病机制。在MALT淋巴瘤中发现的染色体易位包括t(11;18)(q21;q21)、t(1;14)(p22;q32)、t(14;18)(q32;q21)、t(3;14)(p14.1;q32)。最近研究发现了一些新的染色体异常如6q23.3等,它们对淋巴瘤的临床过程及预后等均有影响。MALT淋巴瘤的染色体异常通常激活共同的分子通路核因子(NF)-κB,持续活化的NF-κB使肿瘤细胞增殖或活化,最终导致MALT淋巴瘤的发生。本文就近年来MALT淋巴瘤病因及发病机制的研究进展做一综述。 Mucosa-associated lymphoid tissue (MALT) lymphoma originated outside the lymph nodes is low grade malignant B cell lymphoma. It is the most frequent type of marginal zone non-Hodgkin's lymphoma, that usually occurs in the stomach, salivary gland, thyroid gland and orbital adnexa. Gastric MALT lymphoma accounts for 50% of MALT lymphoma. Gastric MALT lymphoma has been confirmed to relate with Helicobacter pylori (HP) infection, its main pathogenesis is immune reaction, but some patients with chromosome translocation have no response to HP eradication, suggesting presence of other unknow pathogenesis, The chromosome translocations in MALT lymphoma are t ( 11 ; 18 ) (q21;q21), t (1;14) (p22;q32), t (14;18) (q32;q21), t(3;14) (p14.1;q32). Recent studies show some new chromosomal abnormalities such as 6q23.3/A20 and so on, which have some effects on clinical course and prognosis. MALT lymphoma with chromosome abnormalities usually activate common NF-κB molecular pathway, and persistent active NF-κB pathway drives tumor cell proliferative and active, resulting in lymphoma incidence. In this articl, the advances in the etiology and pathogenesis of MALT lymphoma were reviewed.
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2012年第6期1526-1530,共5页 Journal of Experimental Hematology
关键词 黏膜相关淋巴组织淋巴瘤 幽门螺杆菌感染 染色体异常 核因子-ΚB 肿瘤坏死因子α诱导蛋白3 mucosa-associated lymphoid tissue lymphoma Helicobacter pylori infection chromosomalabnormality nuclear factor-KB TNFAIP3
  • 相关文献

参考文献21

  • 1Decaudin D, Ferroni A, Vincent-Salomon A, et al. Ocular adnexal lymphoma and Helicobacter pylori gastric infection. Am J Hematol, 2010;85(9) :645 -649.
  • 2景红梅,克晓燕,董菲.49例MALT淋巴瘤临床资料分析[J].中国实验血液学杂志,2007,15(6):1293-1296. 被引量:8
  • 3Troch M, Raderer M. Gastric MALT lymphoma. Memo-Magazine of European Medical Oncology, 2009 ; 2 ( 3 ) : 130 - 133.
  • 4Ferreri A, Errtverg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Internal Medicine,2009 ;265 (4) : 421 -438.
  • 5Garrison JB, Samuel T, Reed JC. TRAF2-binding B1R1 domain of c-IAP2/MALT1 fusion protein is essential for activation of NF kappa B, Oncogene,2009; 28 ( 13 ) : 1584 - 1593.
  • 6Kingeter LM, Schaefer BC. Maltl and clAP2-Maltl as effectors of NF-kB activation: Kissing cousins or distant relatives? Cellular Signalling, 2010; 22 ( 1 ) : 9 - 22.
  • 7Rosebeck S, Lucas PC, McAllister-Lucas LM. Protease activity of the API2-MALT1 fusion oncoprotein in MALT lymphoma develo- pment and treatment. Future Oncology ,2011 ;7 ( 5 ) : 613 - 617.
  • 8Saito Y, Suzuki H, Imaeda H, et al. Enhanced expression of Micro RNA-142-5p and MicroRNA-155 and suppressed expression of Tp53inpl would be novel molecular biomarkers for gastric Mucosa- Associated Lymphoid Tissue ( MALT ) lyrnphoma, resistant tohelicobacter, pylori eradication. Gastroenterology, 2011 ; 14-0 : 5 Suppl. 1.
  • 9Bhattacharyya S, Borthakur A. B-cell CLL/lymphoma 10 (BCL10) is required for NF-KB production by both canonical and noncanonical pathways and for NF-KB-inducing kinase (NIK) phosphorylation. Journal of Biological Chemistry, 2010 ; 285 ( 1 ) : 522 - 530.
  • 10Li Z, Wang H, Xue L, et al. Emu-BCL10 mice exhibit constitutive activation of both canonical and noncanonical NF- kappaB pathways generating marginal zone (MZ) B-cell expansion as a precursor to splenic MZ lymphoma. Blood,2009; 114 (19): 4158 -4168.

二级参考文献7

  • 1Isaacson P, Wright DH. Malignant lymphoma of mucosa associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer, 1983; 52:1410-1416
  • 2Rohatiner A, d'Amore F, Coiffier B, et al. Report on a workshop convened to discuss the pathological and staging classifications of gastrointestinal tract lymphoma. Ann Oncol, 1994 ; 5 : 397 - 400
  • 3Musshoff K. Clinical staging classification of non-Hodgkin's lymphomas. Strahlentherapie, 1977 ; 153:218 - 221
  • 4Dierlamm J, Baens M, Wlodarska I, et al. The apoptosis inhibitor gene API2 and a novel 18q gene, MLT, are recurrently rearranged in the t ( 11 ; 18 ) ( q21 ; q21 ) associated with mucosa-associated lymphoid tissue lymphomas. Blood, 1999;93 : 3601 -3609
  • 5Thiede C, Morgner A, Alpen B, et al. What role does Helicobacter pylori eradication play in gastric MALT and gastric MALT lymphoma? Gastroenterology, 1997 ; 1136( Suppl ) :S61 - S64
  • 6Liu H, Ye H, Ruskone-Fourmestraux A, et al. T( 11; 18) is a marker for all stage gastric MALT lymphomas that will not respond to H. pylori eradication. Gastroenterology, 2002 ; 122 : 1286 - 1294
  • 7Liu H, Ye H, Dogan A, et al. T( 11 ;18) (q21 ;q21 ) is associated with advanced mucosa-associated lymphoid tissue lymphoma that expresses nuclear BCL10. Blood, 2001 ;98 : 1182 - 1187

共引文献7

同被引文献151

引证文献21

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部